Recalls a homeopathy opportunity

The spate of well-known brand-name recalls of late has created an opportunity of sorts for suppliers of homeopathic remedies, which arguably have a higher safety profile as compared with allopathic medicines.


The most recent recall in the analgesic aisle has come just as PuraMed BioScience is expanding distribution of its LipiGesic-M product for migraines fueled by doctor education. “We found that our early adopters are actually going to be [patients] that are dissatisfied Rx users,” said Russ Mitchell, PuraMed CEO.


Pain relief is one of the largest homeopathic categories sold in mass, according to SPINSscan Conventional data.

Login or Register to post a comment.